Vineet Laboratories Limited (VINEETLAB) — Financial Results
Investor Takeaways
Key Financial Highlights
| Metric | Value | YoY Change |
|---|---|---|
| Revenue | Not available | N/A |
| Net Profit | Not available | N/A |
| EBITDA | Not available | N/A |
| EPS | Not available | |
| OPM | Not available |
What Changed
The filing confirms an upcoming results announcement scheduled for July 15, 2026, with financial results for the quarter and year ended March 31, 2026 to be approved by the board. The company has disclosed insider trading restrictions will remain in effect for 48 hours following the results announcement. The current market capitalization is ₹74.04 Cr. No financial metrics (revenue, profit, EPS, etc.) are provided in the current filing, and no year-on-year changes are available for comparison.
Peer Comparison
| Company | P/E | ROE | ROCE | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Vineet Laboratories Limited | Not available | Not available | Not available | 74.04 |
| Sun Pharmaceutical Industries Limited | 41.28 | 15.11% | 20.34% | 4,50,643.09 |
| Divi's Laboratories Limited | 72.41 | 16.56% | 22.09% | 1,79,470.03 |
| Torrent Pharmaceuticals Limited | 80.06 | N/A | N/A | 1,49,108.91 |
Vineet Laboratories Limited's financial ratios and market capitalization are not available for comparison with peers, as the current filing does not provide standalone financial metrics.
Risks & Concerns
Quarterly Trend
[Not applicable - Quarterly trend data is not provided in the context]
About Vineet Laboratories Limited (VINEETLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Recent Announcements from Vineet Laboratories Limited
-
🔴 Announcement — 24 June 2026
No summary available -
🔴 Financial Results — 30 May 2026
Vineet Laboratories announced on May 30, 2026 that its board meeting was postponed, deferring consideration of the audited standalone financial result... -
🟡 Board Meeting — 30 May 2026
No summary available -
🔴 Corporate Action — 15 May 2026
Vineet Laboratories Limited disclosed its Crisil Ratings Monitoring Agency Report for the quarter ended March 31, 2026, detailing utilization of funds... -
🟡 Corporate Governance — 29 April 2026
Vineet Laboratories Limited disclosed it qualifies for exemption from quarterly corporate governance compliance under SEBI regulations due to its smal...
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when VINEETLAB files new disclosures
Track VINEETLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track VINEETLAB — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research